Select Committee · Public Accounts Committee

Antimicrobial resistance: addressing the risks

Status: Closed Opened: 15 Jan 2025 Closed: 21 Aug 2025 18 recommendations 28 conclusions 1 report

Antimicrobial-resistant (AMR) infections cause an estimated 1.3m deaths globally each year, and rising, and lead to the failure of antibiotics for treating human illness. 67,000 people experienced an AMR infection in 2023. 2,200 of those people died. The UN has predicted that by 2050, AMR will cause 10m or more deaths, comparable to cancer as …

Clear

Reports

1 report
Title HC No. Published Items Response
30th Report - Antimicrobial resistance: addressing the risks HC 646 13 Jun 2025 46 Responded

Recommendations & Conclusions

1 item
13 Recommendation 30th Report - Antimicrobial resistance:… Accepted in Part

New 2024-29 AMR Action Plan targets are less ambitious and potentially insufficient

The 2024–29 National Action Plan (NAP) includes new targets which are less stretching than the targets in the 2019–24 NAP. While the government previously set targets for reductions of 50% in Gram-negative bloodstream infections and 10% in drug-resistant infections, the corresponding targets in the 2024–29 NAP only seek to prevent …

Government response. The government agrees to monitor progress against NAP human health targets biannually and review them annually, with potential for revision if deemed appropriate, but states that preventing an increase in drug-resistant and gram-negative bloodstream infections from the 2019 baseline is …
HM Treasury

Oral evidence sessions

1 session
Date Witnesses
27 Mar 2025 Abigail Seager · Defra, Dr David Partridge · Sheffield Teaching Hospitals NHS Trust, Professor Sir Chris Whitty · Department for Health and Social Care, Professor Sir Stephen Powis · NHS England, Professor Susan Hopkins · UK Health Security Agency (UKHSA), The Lord O'Neill of Gatley View ↗